| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
25,750,000 |
| Market
Cap: |
410.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.1 - $27.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 14.6 |
| Insider 6 Months : 15.4 |
| Insider 3/6 Months : 30.2 |
|
| Guru Rank Number : 140 |
| Guru Rank Value : 7.2 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
179,000 |
211,500 |
257,300 |
699,568 |
| Total Buy Value |
$1,948,031 |
$2,209,591 |
$2,938,957 |
$7,583,356 |
| Total People Bought |
2 |
2 |
3 |
3 |
| Total Buy Transactions |
7 |
9 |
13 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
40,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$504,800 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Opaleye Management Inc. |
10% Owner |
– – • |
2020-06-19 |
4 |
B |
$5.58 |
$195,402 |
I/I |
35,000 |
2,585,000 |
1.5 |
-16% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-06-04 |
4 |
B |
$5.79 |
$57,861 |
I/I |
10,000 |
2,550,000 |
1.5 |
-0% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-06-03 |
4 |
B |
$5.74 |
$118,308 |
I/I |
20,600 |
2,540,000 |
1.5 |
3% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-06-02 |
4 |
B |
$5.69 |
$110,339 |
I/I |
19,400 |
2,519,400 |
1.5 |
2% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-05-22 |
4 |
B |
$5.02 |
$69,589 |
I/I |
13,804 |
125,000 |
1.5 |
17% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-05-21 |
4 |
B |
$4.66 |
$49,338 |
I/I |
10,596 |
120,000 |
1.5 |
14% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-05-20 |
4 |
B |
$4.47 |
$6,739 |
I/I |
1,500 |
119,800 |
1.5 |
18% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,599,100 |
|
28% |
|
| Austin Stephen G |
Director |
– • – |
2020-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,218 |
91,987 |
|
- |
|
| Baum Mark L |
Chief Executive Officer |
• • – |
2019-11-22 |
4 |
OE |
$1.79 |
$279,240 |
I/I |
156,000 |
598,126 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2019-11-22 |
4 |
OE |
$1.79 |
$69,810 |
D/D |
39,000 |
123,000 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-11-11 |
4 |
AS |
$4.75 |
$30,875 |
D/D |
(6,500) |
797,327 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-10-07 |
4 |
AS |
$5.25 |
$34,125 |
D/D |
(6,500) |
803,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-09-09 |
4 |
AS |
$5.67 |
$36,855 |
D/D |
(6,500) |
810,327 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-08-12 |
4 |
AS |
$6.89 |
$44,785 |
D/D |
(6,500) |
816,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-07-15 |
4 |
AS |
$7.91 |
$51,415 |
D/D |
(6,500) |
823,327 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-06-03 |
4 |
AS |
$5.78 |
$57,800 |
D/D |
(10,000) |
829,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-05-01 |
4 |
AS |
$4.57 |
$45,700 |
D/D |
(10,000) |
839,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-04-01 |
4 |
AS |
$4.77 |
$47,700 |
D/D |
(10,000) |
849,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-03-01 |
4 |
AS |
$6.91 |
$69,100 |
D/D |
(10,000) |
859,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-02-01 |
4 |
AS |
$5.86 |
$58,600 |
D/D |
(10,000) |
869,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2019-01-02 |
4 |
AS |
$5.33 |
$53,300 |
D/D |
(10,000) |
879,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2018-12-03 |
4 |
AS |
$4.64 |
$46,400 |
D/D |
(10,000) |
889,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2018-11-01 |
4 |
AS |
$4.21 |
$42,100 |
D/D |
(10,000) |
899,827 |
|
- |
|
| Kammer Robert J |
Director |
– • – |
2018-10-15 |
4 |
AS |
$3.00 |
$30,000 |
D/D |
(10,000) |
909,827 |
|
- |
|
134 Records found
|
|
Page 4 of 6 |
|
|
0.31 (1.94%) 
